Pharming Group N.V. is a Dutch biotechnology company that specializes in the development and commercialization of innovative drugs targeting genetically determined diseases and immune disorders. The company is particularly known for its work in producing therapeutic proteins, including medications for the treatment of rare diseases. Pharming is recognized for its research in genetic therapy and recombinant biotechnology, especially concerning the production of medicinal substances aimed at improving the quality of life for patients with severe conditions.